Reilly Group creates public affairs and corporate social responsibility programs to advance client’s goals and drive results. Program success and sustainability are a result of our ability to analyze the environment, then develop and implement a strategic roadmap bringing stakeholders together to solve pressing problems through policy, programs, and advocacy aimed at improving health and the quality of life for communities.
We developed and co-lead the Mind the Gap Collective Impact Initiative which includes over 40 leading experts from national organizations to ensure Perinatal Mental Health is a national priority.
Impact
Conducted a Landscape Analysis on Perinatal Mental Health
Developed the Mind the Gap Coalition comprised of 40 active professional, patient, government, healthcare, and advocacy Organizations
Convened the first of it’s kind National Advisory Workgroup Meeting on Perinatal Mental Health
Built consensus on a range of strategic priorities to advance policy and legislation on the state and federal level
Published the National Strategic Report on Unaddressed and Untreated Perinatal Mental Health (see the report below)
We developed and co-lead Community Conversations on Alzheimer’s, a signature public affairs initiative launched in major US cities positioning our client as innovative leaders and catalyzing positive outcomes.
Impact
Collaborated with 500+ leading advocacy organizations, academic research centers, legislators and government in 10 major US cities
Trained over 20K health professionals
Generated over a million dollars in grant funding
Launched county and state-wide sustained policy initiatives in San Francisco, San Jose, Philadelphia, Atlanta and Miami going strong two years later
Created 2.0 version that will expand to ten new US cities
Received commendations from the Centers for Disease Control, national organizations, and state governments
Managed Care Company, including Clinical Guidelines in EMR
Encouraged Georgia, Pennsylvania, and Texas to convene state-wide summits on Alzheimer’s, focusing on practice and increasing clinical trial participation
Breast cancer survivors are one of the highest users of Complementary and Alternative Medicine (CAM). As the leading breast cancer organization in the world, Komen was eager to address the issue with science-based information and education to the millions of women they served.
We helped them navigate and understand the burgeoning market of these “therapies” and outline a strategic plan going forward.
We conducted market research with patients, held advisory boards with opinion leaders, and conducted a thorough review of the scientific literature. We provided a detailed roadmap on the CAM education they should provide, programs to develop and why, and the research priorities to fund.
Impact
Created dedicated education portal on CAM therapies for breast cancer survivors
Funded and launched research on top therapies
Published research in The Journal of the Society of Integrative Oncology